Unaffected reaction level in tuberculin skin test by long-term therapy with tumor necrosis factor inhibitors for rheumatoid arthritis

International Journal of Rheumatic Diseases
Shotaro YamamotoSeiji Minota

Abstract

The tuberculin skin test (TST) is used to diagnose tuberculosis; however, the influence of tumor necrosis factor (TNF) inhibitors on the test is unclear. This study investigated whether therapy with TNF inhibitors suppresses the TST reaction due to immunosuppression or whether the TST reaction increases due to reactivation of latent Mycobacterium tuberculosis infection. Ninety-one patients with rheumatoid arthritis receiving TNF inhibitors (40 using infliximab and 51 using etanercept) were studied. The TST was performed before starting TNF inhibitors (T1) and more than 1 year after starting them (T2). At T1, the reaction was negative in 45 patients, weakly positive in 21 patients, moderately positive in 18 patients and strongly positive in seven patients, while the numbers at T2 were 44, 20, 16 and 11, respectively. There were no significant differences of the TST reaction between T1 and T2 in all patients (P = 0.657), patients using infliximab (P = 0.462) or patients using etanercept (P = 1.00). No patients with a strongly positive TST reaction at T1 became negative at T2. However, two patients who were negative at T1 became strongly positive at T2. Although they had no signs of M. tuberculosis infection, isoniazid prophylaxis...Continue Reading

References

Dec 1, 1992·Clinical and Experimental Immunology·C Q ChuR N Maini
Jun 1, 1994·American Journal of Respiratory and Critical Care Medicine·G M CauthenI M Onorato
Apr 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel R RoachWarwick J Britton
Aug 9, 2003·Arthritis and Rheumatism·Carol Dukes Hamilton
Apr 14, 2006·Annals of the Rheumatic Diseases·B E JovenJ L Pablos
Sep 17, 2008·Clinical Rheumatology·Inbal FuchsMahmoud Abu-Shakra
Apr 22, 2011·Journal of the American Academy of Dermatology·Madelaine M Haddican, John Y M Koo
May 14, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·A I Sánchez-Moya, E Dauden
May 24, 2014·Annals of the Rheumatic Diseases·Chrisoula HatzaraDimitrios Vassilopoulos
Oct 30, 2016·Lancet·Josef S SmolenIain B McInnes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.